# The influence of endocrine disruptors on the gut microbiota

**Authors:** Kader UĞUR

PMC · DOI: 10.55730/1300-0144.6124 · Turkish Journal of Medical Sciences · 2025-10-13

## TL;DR

This review explores how endocrine disruptors affect the gut microbiota and may contribute to various health disorders.

## Contribution

The paper provides a comprehensive review of recent findings on how environmental endocrine disruptors influence gut microbiota.

## Key findings

- Endocrine disruptors may disrupt gut microbiota balance, leading to metabolic and cardiovascular disorders.
- EDs are linked to neurological and behavioral disorders through their impact on the gut microbiota.
- The review highlights the need for new treatment strategies incorporating microbiome data.

## Abstract

Endocrine disruptors (EDs) are closely associated with the second brain, the microbiota-derived enteric nervous system, commonly referred to as the gut microbiota. The microbiota plays a crucial role in human health and the development of diseases. In today’s industrialized world, the presence of EDs in air, water, and soil leads to primary human exposure through dermal contact and ingestion. The impact of these EDs on the microbiota remains unclear. EDs that disrupt the balance of the gut microbiota may contribute to a range of disorders, including metabolic (obesity, diabetes mellitus), cardiovascular (vascular stenosis, cerebrovascular disease), reproductive (infertility, ovarian and testicular tumors), neurological (dysfunction of the amygdala, cortex, and cerebellum), and behavioral disorders (dementia, depression, anxiety, and schizophrenia). This review examines the effects of commonly encountered environmental EDs on the gut microbiota and summarizes the most recent findings on this topic. The concept of the microbiota-derived enteric nervous system and the modulation of the hormonal system through interactions between microorganisms and environmental chemicals have prompted specialists in endocrinology and metabolism to reconsider patient management and treatment strategies. This necessitates a comprehensive evaluation of treatment options that incorporate microbiome data. The information presented in this review will help illuminate future research directions and serve as a valuable resource for subsequent studies.

## Linked entities

- **Diseases:** obesity (MONDO:0011122), diabetes mellitus (MONDO:0005015), cerebrovascular disease (MONDO:0011057), dementia (MONDO:0001627), depression (MONDO:0002050), anxiety (MONDO:0005618), schizophrenia (MONDO:0005090)

## Full-text entities

- **Diseases:** dementia (MESH:D003704), diabetes mellitus (MESH:D003920), depression (MESH:D003866), obesity (MESH:D009765), EDs (MESH:D004700), vascular stenosis (MESH:D003251), schizophrenia (MESH:D012559), neurological (MESH:D009461), anxiety (MESH:D001007), behavioral disorders (MESH:D001523), ovarian and testicular tumors (MESH:D010051), infertility (MESH:D007246), cerebrovascular disease (MESH:D002561), dysfunction of the amygdala, cortex, and cerebellum (MESH:D002526)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12758922/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC12758922/full.md

---
Source: https://tomesphere.com/paper/PMC12758922